121 related articles for article (PubMed ID: 1579860)
1. Biliary immune response to orally presented food antigen, ovomucoid, and its potentiation by cholera toxin B subunit.
Sugita-Konishi Y; Kumagai S
Scand J Immunol; 1992 May; 35(5):597-602. PubMed ID: 1579860
[TBL] [Abstract][Full Text] [Related]
2. Immune response of the female rat genital tract after oral and local immunization with keyhole limpet hemocyanin conjugated to the cholera toxin B subunit.
Menge AC; Michalek SM; Russell MW; Mestecky J
Infect Immun; 1993 May; 61(5):2162-71. PubMed ID: 8478106
[TBL] [Abstract][Full Text] [Related]
3. Recombinant cholera toxin B subunit is not an effective mucosal adjuvant for oral immunization of mice against Helicobacter felis.
Blanchard TG; Lycke N; Czinn SJ; Nedrud JG
Immunology; 1998 May; 94(1):22-7. PubMed ID: 9708182
[TBL] [Abstract][Full Text] [Related]
4. Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice.
Price GA; Russell MW; Cornelissen CN
Infect Immun; 2005 Jul; 73(7):3945-53. PubMed ID: 15972481
[TBL] [Abstract][Full Text] [Related]
5. Systemic immune response of young chickens orally immunized with bovine serum albumin.
Mayo SL; Persdotter-Hedlund G; Tufvesson M; Hau J
In Vivo; 2003; 17(3):261-8. PubMed ID: 12929578
[TBL] [Abstract][Full Text] [Related]
6. Role of CD80 and CD86 in host immune responses to the recombinant hemagglutinin domain of Porphyromonas gingivalis gingipain and in the adjuvanticity of cholera toxin B and monophosphoryl lipid A.
Zhang P; Lewis JP; Michalek SM; Katz J
Vaccine; 2007 Aug; 25(33):6201-10. PubMed ID: 17629367
[TBL] [Abstract][Full Text] [Related]
7. The early cellular and humoral immune response to primary and booster oral immunization with cholera toxin B subunit.
Lewis DJ; Novotny P; Dougan G; Griffin GE
Eur J Immunol; 1991 Sep; 21(9):2087-94. PubMed ID: 1889459
[TBL] [Abstract][Full Text] [Related]
8. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin.
Elson CO; Ealding W
J Immunol; 1984 Jun; 132(6):2736-41. PubMed ID: 6233359
[TBL] [Abstract][Full Text] [Related]
9. Cholera toxin B stimulates systemic neutralizing antibodies after intranasal co-immunization with measles virus.
Muller CP; Beauverger P; Schneider F; Jung G; Brons NH
J Gen Virol; 1995 Jun; 76 ( Pt 6)():1371-80. PubMed ID: 7782766
[TBL] [Abstract][Full Text] [Related]
10. Local and systemic antibody responses to dextran-cholera toxin B subunit conjugates.
Bergquist C; Lagergård T; Lindblad M; Holmgren J
Infect Immun; 1995 May; 63(5):2021-5. PubMed ID: 7537252
[TBL] [Abstract][Full Text] [Related]
11. Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H/HeJ mice.
Strindelius L; Filler M; Sjöholm I
Vaccine; 2004 Sep; 22(27-28):3797-808. PubMed ID: 15315861
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of a cholera toxin B subunit Porphyromonas gingivalis fimbrial antigen fusion protein expressed in E. coli.
Kim TG; Huy NX; Kim MY; Jeong DK; Jang YS; Yang MS; Langridge WH; Lee JY
Mol Biotechnol; 2009 Feb; 41(2):157-64. PubMed ID: 18807220
[TBL] [Abstract][Full Text] [Related]
13. Biliary secretion of antibody to dextran following oral immunization with dextran B512.
Tanaka M; Takeda Y; Miyazaki H; Takeo S
Immunopharmacology; 1995 Apr; 29(3):251-9. PubMed ID: 7542646
[TBL] [Abstract][Full Text] [Related]
14. Immunological tools for the assessment of both humoral and cellular immune responses in Foxes (Vulpes vulpes) using ovalbumin and cholera toxin B as an antigenic model.
Rolland-Turner M; Farre G; Muller D; Rouet N; Boue F
Vaccine; 2004 Oct; 22(31-32):4163-72. PubMed ID: 15474706
[TBL] [Abstract][Full Text] [Related]
15. Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle.
Kozlowski PA; Williams SB; Lynch RM; Flanigan TP; Patterson RR; Cu-Uvin S; Neutra MR
J Immunol; 2002 Jul; 169(1):566-74. PubMed ID: 12077289
[TBL] [Abstract][Full Text] [Related]
16. The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice.
Nyström-Asklin J; Adamsson J; Harandi AM
Scand J Immunol; 2008 May; 67(5):431-40. PubMed ID: 18298617
[TBL] [Abstract][Full Text] [Related]
17. Influence of exogenous reproductive hormones on specific antibody production in genital secretions after vaginal vaccination with recombinant cholera toxin B subunit in humans.
Wassen L; Jertborn M
Clin Vaccine Immunol; 2006 Feb; 13(2):202-7. PubMed ID: 16467326
[TBL] [Abstract][Full Text] [Related]
18. Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus.
Liang XP; Lamm ME; Nedrud JG
J Immunol; 1988 Sep; 141(5):1495-501. PubMed ID: 2842395
[TBL] [Abstract][Full Text] [Related]
19. Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant.
Siadat-Pajouh M; Cai L
Viral Immunol; 2001; 14(1):31-47. PubMed ID: 11270595
[TBL] [Abstract][Full Text] [Related]
20. Cholera toxin neutralization: a comparison of purified serum IgG and biliary secretory IgA antibodies.
Pierre P; Langendries A; Vaerman JP
Immunol Lett; 1988 May; 18(1):51-5. PubMed ID: 3378829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
